首页 › 子宫内膜癌 › 康涅狄格州 › New Haven
New Haven CT 子宫内膜癌临床试验
14项针对 子宫内膜癌的研究正在 New Haven及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- Yale Cancer Center, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- Yale Cancer Center, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Yale University, Yale Cancer Center, New Haven
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
招募中3 期
- Yale University School of Medicine, New Haven
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
招募中3 期
- Yale University School of Medicine ( Site 6009), New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
招募中1 期
- Normunity Investigational Site, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Yale University School of Medicine, New Haven
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
招募中2 期
- Smilow Cancer Hospital at Yale New Haven, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- Yale University, Yale Cancer Center, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Yale University, Yale Cancer Center, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
招募中1/2 期
- Yale Cancer Center, New Haven
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- Yale University, New Haven
其他城市的 子宫内膜癌试验
- Houston, TX68 项研究
- New York City, NY52 项研究
- Boston, MA50 项研究
- Arlington, VA39 项研究
- Nashville, TN38 项研究
- Los Angeles, CA34 项研究
- St. Louis, MO29 项研究
- Philadelphia, PA28 项研究
- San Antonio, TX27 项研究
- Columbus, OH25 项研究
- Chicago, IL25 项研究
- Oklahoma City, OK25 项研究
New Haven的其他研究
- 非小细胞肺癌41 项研究
- 乳腺癌38 项研究
- 癌症（所有类型）33 项研究
- 转移性癌症23 项研究
- 肺癌22 项研究
- 头颈鳞状细胞癌22 项研究
- 卵巢癌21 项研究
- 结直肠癌20 项研究
- 前列腺癌20 项研究
- 急性髓系白血病17 项研究
- 酒精使用障碍 (AUD)17 项研究
- 阿片类药物过量17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。